The journey of patients with musculoskeletal complaints in Europe: a cross-sectional European survey
- PMID: 40249450
- PMCID: PMC12008060
- DOI: 10.1007/s00296-025-05863-x
The journey of patients with musculoskeletal complaints in Europe: a cross-sectional European survey
Abstract
Rheumatic and musculoskeletal diseases (RMDs) are highly prevalent and place a significant socioeconomic burden on healthcare systems. However, their diagnosis and management remain suboptimal. This study aimed to analyze healthcare-seeking behaviors, key touchpoints, access barriers, and diagnostic pathways for individuals experiencing initial or progressive symptoms of RMDs across European countries. Understanding these differences is crucial for improving early access to specialized care. A cross-sectional online survey was conducted with 141 participants from seven European countries, including 67 rheumatologists and 39 general practitioners (GPs). The survey assessed initial healthcare-seeking behaviors, delays in diagnosis, and perceived barriers to specialized rheumatology care. Descriptive and inferential statistical methods were used for data analysis. The survey indicated that individuals experiencing RMD symptoms primarily seek information through internet research and GP consultations. Despite their role as primary gatekeepers, GPs' knowledge of RMDs was generally perceived as moderate to low. Significant disparities in access to rheumatological diagnostics, time to diagnosis, and treatment, coupled with organizational barriers between primary and specialist care, were reported across most countries. Spanish participants reported the longest diagnostic delays, while Swedish respondents experienced the shortest. Additionally, access to sacroiliac MRI was limited in Hungary and Spain, whereas glucocorticoids were widely available across all countries according to the participants. The study also revealed that early arthritis clinics were most accessible in the UK from the participants' perspectives. Significant variations in healthcare access for patients with RMDs persist across Europe. Strategies to enhance early detection, including GP education and improved specialist accessibility, are essential to optimizing patient outcomes.
Keywords: Healthcare access barriers; Patient experience; Patient journey; Rheumatic and musculoskeletal diseases, surveys and questionnaires; Surveys and questionnaires.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Primary data collection complied with the General Data Protection Regulation (GDPR) and the Helsinki Declaration. All participants were informed about the research project, and returning the questionnaire was considered as consent. Data were anonymized prior to analysis. The ethics committee of Theodor Fontane Medical School in Brandenburg confirmed that no formal ethical approval was required due to the non-interventional study design, which also applied to the secondary analysis. Brandenburg Medical School’s institutional review board approved the study protocol and materials (Date: 13.02.2024, Reference: 167122023-BO-E). Submission of the survey constitutes the participant’s consent to the survey. Consent for publication: Not applicable. Generative AI and AI-assisted technologies in the writing process: During the preparation of this work the authors used OpenAI ChatGPT (Version 4) in order to improve grammar, language and readability. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication. Conflict of interest: All authors declare no conflicts of interest related to the topic of the study.
Similar articles
-
The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.Clin Rheumatol. 2015 May;34(5):819-29. doi: 10.1007/s10067-014-2841-6. Epub 2014 Dec 14. Clin Rheumatol. 2015. PMID: 25501633 Free PMC article. Review.
-
Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1).RMD Open. 2021 Apr;7(1):e001546. doi: 10.1136/rmdopen-2020-001546. RMD Open. 2021. PMID: 33827969 Free PMC article.
-
Levelling the playing field of RMD research across Europe to address patients' needs: the emerging EULAR Research Centre.RMD Open. 2022 Jun;8(2):e002456. doi: 10.1136/rmdopen-2022-002456. RMD Open. 2022. PMID: 35714997 Free PMC article.
-
Survey of parent and carer experiences and expectations of paediatric rheumatology care in New South Wales.Aust Health Rev. 2017 Aug;41(4):372-377. doi: 10.1071/AH16061. Aust Health Rev. 2017. PMID: 27467400
-
A global perspective on the challenges and opportunities in learning about rheumatic and musculoskeletal diseases in undergraduate medical education : White paper by the World Forum on Rheumatic and Musculoskeletal Diseases (WFRMD).Clin Rheumatol. 2020 Mar;39(3):627-642. doi: 10.1007/s10067-019-04544-y. Epub 2019 May 24. Clin Rheumatol. 2020. PMID: 31127461 Review.
References
-
- Lai KN et al (2016) IgA nephropathy. Nat Rev Dis Primers 2:16001 - PubMed
-
- Burmester GR (2015) Rheumatische und Muskuloskelettale Erkrankungen– eine wissenschaftliche und klinische herausforderung. Drug Res (Stuttg) 65:01 - PubMed
-
- Koch-Institut R (2024) Themenschwerpunkt: Muskuloskelettale Erkrankungen. [cited 2024 30.07.2024]; Available from: https://www.rki.de/DE/Content/Gesundheitsmonitoring/Themen/Chronische_Er...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources